This page was printed from the Northern & Eastern Devon Formulary and Referral site at
Please ensure you are using the current version of this document
MHRA Drug Safety Update November 2013 advises that the use of short-acting β2 agonists (SABAs) for tocolysis in premature labour has been restricted to 48 hours maximum parenteral use under specialist supervision, after a European safety review. Oral SABAs should not be used in any obstetric indication.
Home > Formulary > Chapters > 7. Obstetrics, gynaecology, and urinary-tract disorders > 7.1 Drugs used in obstetrics > 7.1.3 Myometrial relaxants